StockData
Guardian Pharmacy Services, Inc. logo

Guardian Pharmacy Services, Inc. (GRDN) stock

GRDNNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30160% above fair value
$50.33+0.90 (+1.82%)

Close on Nov 17, 2026Market cap $3.19BP/E –Yield –

Guardian Pharmacy Services revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Guardian Pharmacy Services's revenue for the twelve months ending Jun 30, 2026 was $1.46B, up 10.3% year over year. For fiscal 2025 it was $1.45B, up 17.9% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.45B+17.9%
FY2024Dec 31, 2024$1.23B+17.4%
FY2023Dec 31, 2023$1.05B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$351.77M+2.2%
Q1 FY2026Mar 31, 2026$336.60M+2.2%
Q4 FY2025Dec 31, 2025$397.62M+17.4%
Q3 FY2025Sep 30, 2025$377.43M+20.0%
Q2 FY2025Jun 30, 2025$344.33M+14.8%
Q1 FY2025Mar 31, 2025$329.31M+19.6%
Q4 FY2024Dec 31, 2024$338.57M+20.5%
Q3 FY2024Sep 30, 2024$314.39M+19.7%
Q2 FY2024Jun 30, 2024$300.04M–
Q1 FY2024Mar 31, 2024$275.41M–
Q4 FY2023Dec 31, 2023$281.07M–
Q3 FY2023Sep 30, 2023$262.74M–

More Guardian Pharmacy Services figures

See a number that looks wrong?